| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 291.555 | 270.651 | 264.733 | 221.087 | 0 | 8.530 | 8.940 | 5.529 | 4.893 | 11.196 |
| Total Income - EUR | 292.310 | 374.116 | 265.139 | 571.512 | 7 | 8.531 | 11.441 | 10.854 | 5.037 | 11.886 |
| Total Expenses - EUR | 302.314 | 335.646 | 264.671 | 235.013 | 25.452 | 20.652 | 18.187 | 15.126 | 12.413 | 14.615 |
| Gross Profit/Loss - EUR | -10.004 | 38.471 | 468 | 336.499 | -25.445 | -12.121 | -6.746 | -4.272 | -7.376 | -2.729 |
| Net Profit/Loss - EUR | -10.004 | 31.724 | -1.986 | 330.784 | -25.445 | -12.361 | -7.047 | -4.590 | -7.376 | -2.729 |
| Employees | 6 | 6 | 7 | 6 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Farmaclem Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 177.947 | 109.083 | 101.809 | 112.505 | 100.585 | 89.212 | 77.977 | 72.692 | 68.209 | 63.590 |
| Current Assets | 67.013 | 135.479 | 104.199 | 303.090 | 147.721 | 40.576 | 17.318 | 11.806 | 8.351 | 10.334 |
| Inventories | 31.775 | 24.957 | 24.495 | 1.743 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 24.934 | 9.402 | 24.024 | 19.163 | 2.265 | 2.613 | 2.508 | 3.663 | 3.810 | 4.378 |
| Cash | 10.303 | 101.120 | 55.680 | 282.184 | 145.456 | 1.784 | 2.413 | 1.833 | 443 | 2.588 |
| Shareholders Funds | 70.303 | 101.310 | 97.610 | 390.869 | 33.540 | 20.543 | 13.040 | 8.490 | 1.088 | -1.646 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 174.656 | 143.251 | 108.398 | 24.726 | 214.766 | 109.245 | 82.255 | 76.008 | 75.472 | 75.570 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaclem Srl